FGF2 and myocardial infarction: In an animal myocardial infarction model transplanted with ADRCs, the heart function and inhibition of myocardial remodeling are achieved through the release of pro-angiogenic factors such as stromal cell-derived factor-1α, nerve growth factor beta, VEGF, HGF, and bFGF [81].